Experts See Gaps in the Management of Age Related Loss in Bone Mass
While minerals and vitamins such as calcium and vitamin D remain cornerstones of bone health, the rising prevalence of osteoporosis and osteopenia highlights the need for more comprehensive solutions. Bone strength depends not only on minerals but also on the collagen matrix that provides flexibility and resilience. Just as bridges require both concrete and steel, healthy bones rely on collagen to prevent brittleness and fractures. Maintaining skeletal integrity is crucial throughout life, especially as osteopenia – the early stage of bone mass decline – can begin as early as age 35. The risk of fractures doubles every decade, underscoring the importance of proactive bone health management. Experts agree that specific collagen peptides should be integrated into bone health management (Desai et al., 2024).
Enhancing the Formation of New Bone
FORTIBONE® delivers targeted Bioactive Collagen Peptides that stimulate osteoblasts to produce essential collagen and other structural proteins. These peptides function as biological signals, promoting synthesis while inhibiting collagen degradation in the extracellular matrix – the vital scaffold for bone mineralization. Additionally, FORTIBONE® modulates bone remodeling by reducing osteoclast activity, effectively slowing bone loss and enhancing bone density.
Clinically Validated Efficacy of FORTIBONE®
A 12-month, randomized, placebo-controlled, double-blinded clinical trial involving 180 participants with reduced bone mass demonstrated significant improvements in bone mineral density (BMD) at the spine and femoral neck following daily supplementation with 5 g of FORTIBONE®. These results confirm the anabolic effect of FORTIBONE® on bone tissue, establishing it as a scientifically validated solution for combating bone degeneration (König et al, 2018).
Key Advantages of FORTIBONE®
Addressing a Global Health Challenge
Osteoporosis and osteopenia affect millions worldwide, including a large proportion of post-menopausal women and aging populations. In the United States, approximately 44 million people face this condition, with over half of those aged 50 and above at risk. The economic burden is substantial, with costs exceeding €37 billion annually in the European Union and $20 billion in the United States. FORTIBONE® offers a cutting-edge approach to mitigate these challenges through scientifically supported collagen peptide technology.
Versatile Applications For Modern Consumers
Designed to meet the needs of older adults and active individuals prioritizing long-term bone wellness, FORTIBONE® integrates seamlessly into various supplement formats such as sachets, vials, gels, and functional foods. Its clean label profile—free from E numbers—combined with high digestibility and non-allergenic properties, makes it an ideal ingredient for next-generation bone health products.
Leverage FORTIBONE®
To Develop Innovative Bone Health Solutions
You benefit from GELITA’s technological expertise and global reach by incorporating FORTIBONE® into your product portfolio. Enhance your dietary supplements and functional foods with a clinically proven ingredient that addresses bone health holistically. Partner with GELITA to deliver trusted, science-backed solutions that meet the evolving demands of health-conscious consumers worldwide.
